CVRx, Inc., a private medical device company, has completed a fifth round of private equity financing totaling $84 million. The company has developed the Rheos® System, the only implantable device designed to control hypertension, or high blood pressure, a leading cause of heart and kidney disease, stroke and death. This device is intended to provide […]
Less
More
EBR Systems Inc., a development stage, venture-backed medical device company, completed Series C financing of $35M on June 12, 2008. EBR Systems is developing a novel technology, the first leadless pacing system for cardiac stimulation applications. The funding will be used to complete product development and to initiate clinical trials of an implantable pacing device […]
CardioKinetix Inc., a Redwood City, Calif.-based heart failure treatment company, secured $14.5 million in Series C funding. CardioKinetix, Inc. develops technology for the treatment of congestive heart failure. The company offers medical implants that treat ventricular wall motion abnormalities, which occur after an AMI and can progress to end-stage heart failure.
Cameron Health Inc. has raised $51.5 million. The company is working on a new type of implantable defibrillator that’s designed to be easier to implant and program than existing models. Implantable defibrillators administer shocks to the hearts of people who are at risk of cardiac arrest - a critical condition in which the heart simply […]
MindFrame Inc., a Lake Forrest, Calif.-based developer of mechanical devices for ischemic stroke treatment, has raised $6 million in Series A funding. “Ischemic stroke occurs when an artery to the brain is blocked. The brain depends on its arteries to bring fresh blood from the heart and lungs. The blood carries oxygen and nutrients to […]
CoAxia, Inc. of Maple Grove, MN, today announced the closing of an additional $11.5M financing from current investors to support the continuation of CoAxia’s ongoing clinical trials. The investment is an extension of the previously announced C Round and will allow CoAxia to continue its SENTIS pivotal FDA trial of NeuroFlo Perfusion Augmentation Therapy in […]
CyberHeart Inc. raised $9 million in Series A funding. CyberHeart is a developmental stage medical device company founded in 2005 by Thomas Fogarty, MD and Roderick Young. The company is developing a non-invasive radiosurgical system for cardiac applications. Utilizing the most accurate robotic radiosurgical system and the only system able to dynamically detect, track, and […]
Hercules provides $250,000 direct equity investment to Crux Biomedical, Inc. Crux, a privately held medical device firm, is developing an Inferior Vena Cava (IVC) filter for the treatment and prevention of pulmonary embolism (PE). “According to Crux Biomedical, approximately 600,000 patients develop a PE every year,” said Brandt Roberts of Hercules. “With no clear leader […]
Atritech, Inc., a clinical stage medical device company, announced today that it has completed a $22 million round of financing. Atritech’s WATCHMAN(R) device is designed to keep harmful sized blood clots from entering a patient’s blood stream, potentially causing a stroke. Patients with atrial fibrillation (a heart condition which causes the upper chambers of […]
Paracor Medical, Inc., a private venture-backed company developing device-based treatments for heart failure, today announced the closing of $44.35 million in its Series D funding Paracor Medical, Inc. was formed in 1999 with the goal of developing a family of device-based therapies to attenuate the progression of heart failure for the 5 million U. […]
chronic heart failure